Carroll Community College

NURS 140Medication Table

Medication Name generic name trade name

Classification

RouteUsual Dose

Most common side effects

Nursing Assessments *Patient dose*Frequency

*Why med is ordered for this patient:

Generic: AcetaminophenTrade: Tylenol

Classification: Antipyretics, Nonopioid Analgesics

PO 325-650 MG Q4-6HR

IV 1000 MG Q6H OR 650 MG Q4H

RECT 325-650 MG Q4-6HR

ANIEXTYDYSPNEAHYPO/HYPERTENSIVERENAL FAILUREMUSCLE SPAMSHEPATOTOXICITY

*Overall health status and alcohol usage before administration.*For pain: assess type, location, and intensity prior to and 30-60 min following administration*For fever: assess fever, note presence signs*Monitor labs: LDH, AST, ALT and PTINR*Assess for toxicity or overdose

650 MG PO Q6H PRN (Temp > 38.5)

On admission, patient presented with a fever.

Generic: Atorvastatin CalciumTrade: Lipitor

Classification: Lipid-lowering agents, HMG-CoA reductase inhibitor

(lowers total and LDL clolesterol and trigylcerides)

PO 10-20 MG ONCE DAILY INITITALLY, MAY INCREASE Q2-4 WEEKS UP TO 80 MG/DAY

ABD CRAMPINGCONSTIPATIONFLATUSHEARTBURNRASHESRHABDOMYOLYSIS

*Obtain a dietary history (fat consumption)*Monitor labs: LFT*Assess for toxicity or overdose-muscle tenderness, check CK levels

40 MG PO QPM

Generic: BisacodylTrade: Dulcolax

Classification: Laxative

PO 5-15 MG/DAY AS A SINGLE DOSE

ABD CRAMPINGNAUSEA

*Assess abdomen-presence and pattern of bowel sounds or function*Assess stool-color,

10 MG RC QDAY PRN(UNABLE TO TAKE PO)

Abdominal ultrasound showed the presence of gallstone which

5/2/2023

(stimulates peristalsis-evacuation of the colon)

RECT 10 MG/DAY SINGLE DOSE

consistency, and amount could cause constipation

Generic: CarvedilolTrade: Coreg

Classification: Antihypertensive, beta blocker

(Helps decrease heart rate and blood pressure, improves cardiac output, slows progression of HF)

PO:For hypertension-6.25 MG BID DAILY

For HF- 3.125 MG BID DAILY

For MI- 6.25 MG BID DAILY

(dose may be increase)

DIZZINESSFATIGUEWEAKNESSDIARRHEAERECTILE DYSFUNCTIONHYERGLYCEMIA

*Monitor BP and pulse*Monitor I/O*Monitor labs: BUN, Lipids, K, Triglyceride, uric acid*Assess for toxicity or overdose-bradycardia, SOB, dizziness, seizures

9.375 MG PO BID Patient has a history of HTN and MI

Generic: Dronedarone HydrochlorideTrade: Multaq

Classification: Antiarrythmic, bensofurans

(Suppression of AF/AFL)

PO 400 MG BID DAILY

WEAKNESSABD PAINDIARRHEAVOMITINGHFHEPATOTOXICITY

*Assess S/S of AF*Monitor EKG*Monitor Labs: hepatic enzyme, K, Mag, Creatinine*Assess for toxicity or overdose-S/S of hepatic injury

400 MG PO BID Patient has a history of dysrhythmia

Generic: Diphenhydramine HCLTrade: Benadryl

POFor allergy:25-50 MG Q4-

DROWINESSANOREXIADRY MOUTH

*Determine purpose of medication*Assess for patency of

25 MG PO Q6H PRN Patient has a history of allergies:-seafood

5/2/2023

Classification: Allergy, cold, and cough remedies, antihistamines, antitussive

(decreases the symptoms of histamine excess and suppress cough)

6HR

For cough:25 MG Q4H PRN

IV (IM)25-50 MG Q4H PRN

TOPICALAPPY TO AFFECT ARE UP TO 3-4 TIMES DAILY

airway*Assess for degree allergy S/S, cough, and pruritus*Assess movement disorder*Assess sleep patterns*Assess motion sickness*Monitor lab: may decrease skin reaction to allergy testing

-chocolate-pineapple-verapamil (HTN med)

Generic: GabapentinTrade: Neurontin

Classification: analgesic adjuncts, anticonvulsants, mood stabilizer

(decreases incidence of seizures, post herpetic pain, leg restlessness)

POFor neuropathic pain:100 MG TID DAILY INITIALLY. TITRATE WEEKLY BY 300 MG/DAY-MAX DOSE 3600 MG/DAY

CONFUSIONDEPRESSIONDROWINESSATAXIASUCIDAL THOUGHTS

MUTIL-ORGAN HYPERSENSITIVELY REACTIONS

*Monitor behavior changes*For neuropathic pain: assess location, characteristics, and intensity of pain*Monitor lab: could cause false reading of urinary protein

100 MG PO TID Use to treat patient’s neuropathic pain. Patient is schedule for bone scan today for further studies

Generic: Hydromorphine HCLTrade: Diaudid

Classification: Opioid agonist

(Decrease in moderate to serve pain)

PO4-8 MG Q3-4H INITIALLY

IV,IM,SUBCUT0.015 MG/KG Q3-4 HR PRN INTIALLY

RESP. DEPRESSIONCONFUSIONSEDATIONHYPOTENSIONCONSTIPATION

*Assess BP, pulse, and resp. (before, periodically, and after administration)*Asses bowel function*Assess pain*Monitor lab: may increase plasma amylase and lipase*Assess for toxicity or overdose-resp. depression to coma

0.5 MG IV Q3H PRN(MODERATE PAIN 4-6 IF PT IS NPO OR PAIN IS NOT CONTROLLED BY ORAL MEDICATION)

Patient complains of lower side back pain

Generic: PO DIZZINESS *Assess for sulfa 12.5 MG PO QDAY Patient has a history

5/2/2023

HydroclorothiazideTrade:Urozide

Classification: Antihypertensive, diuretic

(Lowers BP and diuresis with mobilization of edema)

12.5-100 MG/DAILY IN 1-2 DIVIDED DOSES

MUSCLE CRAPMSHYPOKALEMIASJS

SULFA ALLERGIES!!!

allergies*Monitor BP (before/periodically), I/O, daily weights*Assess neuro and musculoskeletal*Monitor K, BS, BUN, CREAT, and URIC ACID

of HTN and bladder problems

Generic: LorazepamTrade: Ativan

Classification: antianxiety, sedative/hypnotic

(sedation and decreases anxiety/seizures)

PO1-3 MG 2-3X DAILY

SL2-3 MG/DAY IN DIVIDED DOSES, NOT EXCEED 6 MG/DAY

IM50MCG 2HR BEFORE SURGERY

IV44MCG 15-20MINS BEFORE SURGERY

DIZZINESSDROWINESSLETHARGY

IV RAPID USE:APNEACARDAIC ARRESS

*Geri-assess for CNS reactions (risk for falls)*For anxiety- assess degree and manifestation of anxiety and mental status*Monitor labs: renal, hepatic, hem function*Assess for toxicity or overdose-FLUMAZENIL=ANTIDOTE(do not use with seizure)

0.5 MG PO Q8H PRN

Patient is claustrophobic and got a little anxious prior to MRI scan. Patient was treated with anxiety medication and test was change to a bone scan instead.

Generic: Lidocaine HCL 5%Trade: KCL, K-Dur

Classification: Supplement

APPLY TO AFFECTED AREA TP UD PRN

Generic: Magnesium Hydrox (Lax)Trade: KCL, K-Dur

30 ML PO Q12H PRN

5/2/2023

Classification: Supplement

Generic: Ondansetron HCLTrade: KCL, K-Dur

Classification: Supplement

4 MG IV Q6H PRN

Generic: Potassium ChlorideTrade: KCL, K-Dur

Classification: Supplement

20 MEG PO BID

Generic: Promethazine HCLTrade: KCL, K-Dur

Classification: Supplement

25 MG PO TID PRN

Generic: Vancomycin HCL/D5WTrade: KCL, K-Dur

Classification: Supplement

1250 MG IV(150ML/HR INFUSE OVER 120 MINS-1600/0400)

Generic: WarfarinTrade: KCL, K-Dur

Classification: Supplement

DOSINF AS PER PHARMACYTODAY INR 1.95MG PO AT 1800 (2/24)

Generic: Ondansetron HCLTrade: KCL, K-Dur

5/2/2023

Classification: Supplement

5/2/2023